Initiating buprenorphine for OUD via telehealth enhanced patients’ likelihood of staying in treatment longer compared with starting treatment in a nontelehealth setting, according to new research in JAMA Network Open.

A new report from Surescripts finds that more pharmacists are electronically prescribing medications as they assist with managing chronic diseases for patients.

Results from a new study in JAMA found that the Million Hearts Model, which paid participating health care organizations to assess and reduce patients’ CVD risk, decreased myocardial infarction and stroke rates for Medicare fee-for-service beneficiaries aged 40 to 79 years at high or medium risk for these events.

The use of metformin among pregnant women with gestational diabetes was associated with enhanced glycemic control and reduced gestational weight gain, according to a randomized, placebo-controlled study published in JAMA.

DEA will continue to allow providers to use telemedicine to prescribe certain controlled substances through the end of 2024.